This study is looking at whether Lemborexant can help people with epilepsy who also have trouble sleeping (insomnia). You might be able to join if you are an adult (18 or older) with sleep-related focal epilepsy and use contraception. However, you cannot participate if you've recently changed your epilepsy medication, are pregnant or breastfeeding, have liver problems, or have breathing issues. The researchers will measure how well Lemborexant works by looking at how much time you spend awake after falling asleep (WASO) over 36 days. The study is currently unclear about its recruitment status.

Study design

This interventional study plans to enroll 26 participants. It compares Lemborexant to a placebo (an inactive substance).

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint is measured at 36 days, suggesting follow-up for at least this duration.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.